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The effect of ellagic acid on the repair 
process of periodontal defects related 
to experimental periodontitis in rats
Objective: This study aims to evaluate the effect of ellagic acid (EA) by 
measuring the levels of alveolar bone resorption and inflammatory and oxidative 
stress markers in the periodontal tissues and serum on the periodontal repair 
process related to experimental periodontitis in rats. Methodology: Forty Wistar rats 
were divided into four study groups as follows: Group 1=healthy control (n=10); 
Group 2=EA control (15 mg/kg)(n=10); Group 3=periodontitis (n=10); Group 
4=periodontitis+EA (15 mg/kg) (n=10). The periodontitis model was established 
by ligating bilateral mandibular first molars for 14 days. Then, rats were given 
normal saline or EA for another 14 days by gavage administration. Serum and 
gingiva myeloperoxidase (MPO) activity, 8-hydroxydeoxyguanosine(8-OHdG), 
and glutathione (GSH) levels were analyzed by ELISA. İmmunohistochemical 
analysis was used to detect Interleukin (IL)-6, IL-10, and tumor necrosis factor-
alpha (TNF-α) immunoreactivities in the periodontal tissues. Alveolar bone loss 
(ABL) and attachment loss (AL) was evaluated by histomorphometry analysis. 
Results: ABL and AL were statistically higher in group 3 than in groups 1, 2 and 
4 and in group 4 than in groups 1 and 2 (p<0.05). MPO activities in gingival 
tissue and serum were significantly increased in group 3 compared to groups 
1 and 2 (p<0.05). Significantly higher serum GSH levels, lower gingiva, and 
serum 8-OHdG levels, and MPO activity were observed in group 4 compared 
to group 3 (p<0.05). Rats with periodontitis (group 3) expressed significantly 
higher immunoreactivities of IL-6 and TNF-α and lower IL-10 immunoreactivity 
compared to those other groups (p<0.05). IL-6 and TNF-α immunoreactivities 
significantly decreased and IL-10 immunoreactivity increased in group 4 after 
the use of EA compared to group 3 (p<0.001). Conclusions: Our findings 
showed that EA provides significant improvements on gingival oxidative stress 
and inflammatory markers and alveolar bone resorption in the repair process 
associated with experimental periodontitis. Therefore, EA may have a therapeutic 
potential on periodontitis.
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Introduction 
Periodontitis is one of the most widespread 
infectious inflammatory diseases. It occurs due to an 
imbalance between dental plaque bacteria and the 
host’s inflammatory and immune responses.1 During 
periodontitis, host cells produce excessive amounts of 
reactive oxygen species (ROS), such as those produced 
by myeloperoxidase (MPO), 8-hydroxydeoxyguanosine 
(8-OHdG) and inflammatory cytokines, such as tumor 
necrosis factor-alpha (TNF-α) and interleukin (IL)-6, 
in response to bacterial infiltration. The release of 
these markers leads to the destruction of periodontal 
tissues.2–4
The elimination of microbial dental biofilms is 
essential to the treatment of periodontal diseases.1,5 
Mechanical removal (scaling and root planning) is not 
sufficient for the complete elimination of periodontal 
microflora.1,5 Therefore, pharmacologic agents 
(antiseptics, nonsteroidal anti-inflammatory drugs, 
and antibiotics) are used as adjunctive therapy to 
ensure the destruction of microorganisms.6 When these 
drugs are used systemically with high doses, they can 
lead to complications such as antibiotic resistance and 
other side effects.1 This is the reason why alternative 
natural products are needed for therapeutic use.1,6,7 
For such purpose, polyphenolic compounds, which 
have antioxidant, anti-cancer, and anti-inflammatory 
effects have been suggested as potential candidates.8,9 
Polyphenols have been reported to have several 
biological activities; they prevent oral disease, 
inactivate bacterial toxins, promote the antioxidant 
activity of oral fluids, exhibit antibacterial activity 
against periodontal pathogens, and can inhibit the 
proteolytic activity of Porphyromonas gingivalis.3,9,10
Ellagic acid (EA), a polyphenol, is found in many 
fruits, including strawberries, walnuts, pomegranates, 
and grapes, and many medicinal plants.11,12 EA has 
been reported to exhibit antioxidant, anti-cancer, 
anti-allergic, antiproliferative, and anti-inflammatory 
activities, as well as radical scavenging activity and 
inhibition of lipid peroxidation.11–14 Ogawa, et al.15 
(2002) reported that EA eliminated superoxide and 
hydroxy anions. They stated that EA’s effect was 
stronger than that of α-tocopherol and it was as 
potent as superoxide dismutase (SOD). EA has been 
suggested to suppress the production of various 
cytokines, such as IL-1β, IL-8, and TNF-α.15 A recent 
review concluded that EA could be a promising 
agent for the treatment of various chronic diseases, 
especially Alzheimer’s disease, ulcerative colitis, 
Crohn’s disease, and diabetes.16 Moreover, Promsong, 
et al.17 (2015) showed that EA protects human gingival 
epithelial cells by reducing IL-2 and IL-8 levels and 
suppressing defense factors, such as human beta-
defensin 2 (hBD2) and secretory leukocyte protease 
inhibitor (SLPI). Bakkiyaraj, et al.7 (2013) showed 
that the anti-biofilm activity of EA was greater in 
various bacterial pathogens (Staphylococcus aureus, 
methicillin-resistant S. aureus [MRSA] compared to 
Candida albicans. 
Considering these observations, since ROS 
and inflammatory cytokines are involved in the 
pathogenesis of periodontitis, we theorize that EA 
exhibits its anti-inflammatory and antioxidant effects 
in periodontal lesions by scavenging radicals and 
suppressing cytokine production. However, no studies 
have investigated the effect of EA in periodontitis. 
Therefore, our study aimed to evaluate the therapeutic 
effects of EA administered orally, measuring gingiva 
and serum MPO, 8-OHdG, and glutathione (GSH) 
levels, expression of IL-6, IL-10, and TNF-α in gingiva 
and alveolar bone loss on repair process associated 
with experimental periodontitis (EP) in rats. 
Methodology
Animals
Forty systemically and periodontally healthy adult 
(8 weeks old) male Wistar albino rats weighing an 
average of 220 to 250 kg were used in our study. 
Rats were placed in separate plastic cages, provided 
food and water being ad libitum, housed at a room 
temperature of 22±1°C within 50% humidity 
conditions in a 12-hour light/dark cycle. All animal 
care and experimental protocols were approved by 
the Ethical Committee of Animal Research of Bulent 
Ecevit University in Zonguldak, Turkey (Protocol 
number 2013-29-02/10) in accordance with both 
the Guide for Care and Use of Laboratory Animals 
(National Institute of Health, Bethesda, MD, USA) and 
the ARRIVE guidelines.18
Sample size could be estimated before the study 
due to the lack of precise information available 
regarding ellagic acid effects in experimental 
periodontitis. We, therefore, based our estimates on 
the pilot study, which suggested 6 rats in each group. 
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The sample size was estimated based on the results 
of biochemical biomarkers levels in gingival tissue 
between ellagic acid application groups and their 
control groups. A sample size of 10 per group was 
required for detection of a significant difference (80% 
power, two-sided 5% significant level).
The animals were randomly divided into four groups 
of ten rats each. 1) Group 1=periodontally healthy 
control (n=10), in which each rat was gavaged daily 
with 2 mL of saline by gastric intubation for 14 days; 
2) Group 2=periodontally healthy rats+ EA control (15 
mg/kg)(n=10), in which rat was gavaged daily with 
2 mL of saline containing EA by gastric intubation for 
14 days; 3) Group 3=experimental periodontitis group 
(n=10), in which each rat was gavaged daily with 2 mL 
of saline by gastric intubation for 14 days; 4) Group 
4=experimental periodontitis group + EA (15 mg/kg)
(n=10), in which rat was gavaged daily with 2 mL of 
saline containing EA by gastric intubation for 14 days.19 
The dosage and administration form of drugs were 
determined based on the literature.19 Drug treatment 
began after periodontitis was induced. 
Experimental periodontitis and repair protocol
A ligature-induced periodontitis model was created 
due to the induction of EP.20 With the rats under 
general anesthesia through intraperitoneal injection of 
ketamine (100 mg/kg of body weight) and xylazine1 
(10 mg/kg of body weight), EP was induced by the 
placement of sterile 3–0 silk ligatures in a subgingival 
position around the mandibular first molars (left and 
right) in all groups for 14 days, except groups 1 and 
2. The ligatures contributed to periodontal diseases, 
facilitating the movement and passage of bacteria 
within the gingival cavities.21 All ligatures in groups 3 
and 4 were removed to allow periodontal repair after 
14 days of periodontitis induction22. Then, rats started 
receiving once-daily normal saline or EA for 14 days 
by gavage administration. The rats were euthanized 
on the 28th day.
Treatment with ellagic acid 
The EA (Sigma Chemical Company, St Louis, MO, 
USA) treatment in rats was conducted as described 
by Kannan, Quine, and Sangeetha19 (2012). As soon 
as EA display poor solubility in water, the treatment 
in each animal was carried out with a suspension of 
ellagic in water at a dose of 15mg/kg. The suspension 
was homogenized with the syringe used in the oral 
administration before each animal treatment. EA (15 
mg\kg) was once-daily administered by gavage for 14 
days, starting after the ligature removal in group 4. 
Sample collection
All rats were anesthetized and 5mL of venous blood 
was drained out through cardiac punctures for serum 
analyses. Blood samples were centrifuged (Shimadzu 
UV160A, SNo:28006648, Kyoto, Japan) at 3000 g 
and room temperature for 10 minutes, enabling the 
collection of serum, which were then placed at −70°C 
before biochemical analysis. Block biopsy samples, 
including the gingiva and alveolar bone tissue, were 
removed from the molar regions of the mandibles. 
For histological analysis, the left mandibular molar 
regions were resected en bloc from each rat and 
were fixed in 4% paraformaldehyde in 0.1 mol/L 
phosphate buffer (pH 7.4) for 1 day. Gingival biopsy 
samples of the right mandibular molar regions were 
collected and immediately frozen and kept at −70°C 
until biochemical analysis.
Biochemical analysis
The gingival tissue was blotted before being weighed 
upon a microbalance. The tissues were cryogenically 
frozen using liquid nitrogen. Subsequently, the tissues 
were manually grounded, by placing them within 
Eppendorf tubes containing a required volume of PBS 
(pH 7.4, 10mM), diluted to 10 mg. tissue/mL PBS. 
This was sonicated (METU Electromechanical, Serial 
No.30607, Berlin, Germany) for 10 minutes at 4°C 
with 220V. On the day of evaluation, homogenates 
defrosted within the room from the samples were 
centrifuged (SIGMA 3K30, Serial No.76262, Osterode 
am Harz, Germany) at 4°C and 15000g for 5 minutes 
and the supernatants were arranged for subsequent 
GSH, MPO, and 8-OHdG analysis. Gingival tissue and 
serum MPO activity, GSH, and 8-OHdG levels were 
evaluated using commercially marketed enzyme-
linked immunosorbent assay (ELISA) kits (Cayman 
Chemical Company, Item No. 589320 Ann Arbor, MI, 
USA). The quantum of protein present within the 
tissues was observed by the Lowry method,23 with the 
results expressed as mg per protein. The conclusions 
were expressed in microgram (µg) of cytokine\
mg of protein (µg\mg.protein) within the gingival 
tissues, and in ng\mL within the serum, barring GSH 
concentrations. The GSH concentration was expressed 
as mg\ mg prot within the gingival tissues, and as 
mg\L within the serum.
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Immunohistochemical analyses
Avidin-biotin peroxidase method was used for the 
immunohistochemical studies to investigate the anti-IL 
10, IL-6, and TNF-α activities. Cross-sections prepared 
from the mandible tissue blocks in 4 μm thickness were 
incubated at 60°C. Tissues were rinsed with sequential 
xylol and alcohol solutions for deparaffinization and 
distilled water was used to remove the alcohol from 
dehydrated tissues. To expose the receptor areas 
within the tissue blocked by formaldehyde, citrate 
buffer (pH 6.0) (Lab Vision, Fremont, USA) was applied 
to the tissues under high temperatures. Following 
the antigen retrieval procedure, the tissues were left 
in the room to cool down for 20 minutes and then 
rinsed with distilled water to remove the citrate. Each 
Tissue was rinsed with phosphate buffer saline (PBS, 
Ph: 7.4) three times for 3 minutes, exposed to 3% 
hydrogen peroxide (Lab Vision, Fremont, USA) for 
15 minutes, and the endogenous peroxidase activity 
was blocked and rinsed with PBS. Ultra V block (Lab 
Vision, Thermo Scientific) was applied for 5 minutes 
to prevent nonspecific binding. Following the blocking 
stage, the sections were left at room temperature for 
45 minutes without being washed and were exposed 
to anti-IL-10 antibody (ab9722, Abcam, UK), anti-IL-6 
antibody (ab6672, Abcam, UK), anti-TNF-α antibody 
(NB600-587, Novus biological, USA) and primer 
antibodies that were prepared 1/100 proportion. All 
primer antibodies were incubated for an hour at 40ºC. 
Then they were rinsed with PBS following the primer 
antibody. A secondary antibody (Lab Vision, Thermo 
Scientific) was applied for 10 minutes. They were 
rinsed with PBS and were exposed to streptavidin 
peroxidase enzyme (Lab Vision, Thermo Scientific) 
complex for 10 minutes. Each tissue was rinsed once 
more with PBS. Finally, chromagen DAB (Spring 
Bioscience) containing the diaminobenzidine substrate 
(Spring Bioscience) was added to the medium and 
was put aside for about 5-10 minutes to ensure the 
immune reaction. Mayer’s hematoxylin was used as the 
background strain. The slides were rinsed with serial 
alcohol solutions with diminishing concentrations. They 
were kept in xylol for 20 minutes and were coated 
with entallan. All sections were evaluated in the light 
microscope Axio Scope A1 Imager Microscope (Carl 
Zeiss, Oberkochen, Germany).
The immunoreactivities of IL-6, IL-10, and TNF-α 
proteins in the periodontal ligament were scored by 
one researcher (KG), using a histologic scoring method 
(HScore).24 Staining intensity was semiquantitatively 
scored according to the following categories: 0, absent; 
1, weak; 2, moderate; and 3, intense. The formula was 
HScore = S Pi (i + 1), in which i represents the intensity 
scores: Pi, the percentage of stained cells; and 1,the 
correction factor. In total, 100 positive stained cells 
in the field were evaluated according to the staining 
intensity and formulated as follows [1×(%cells1+)+
2×(%cells2+)+3×(%cells 3+)].
Histomorphometric analysis
The left side of the mandible detached from within 
the gingiva was fixated with 10% neutral buffered 
formalin. The samples collected were decalcified in 
8% formic acid (14 days) and subsequently embedded 
within paraffin. Serialized paraffin sections (5 µm) 
were concluded from within the mesiodistal aspects 
within the mandibular first molars. Three of the 
sections, reflective of the central parameters of the 
individual tooth, were observed and thereafter stained 
with hematoxylin and eosin (H&E).
Individual sections were stained with H&E and the 
parameters assessed included: 1) the percentage 
of alveolar bone in the furcation area, 2) alveolar 
bone loss (ABL), and 3) attachment loss (AL). The 
percentage ratios of alveolar bone area upon individual 
specimens were concluded as a ratio of the alveolar 
bone area versus the furcation area. The alveolar 
bone area was concluded as a mix of the trabecular 
bone area and the bone marrow area in furcation. The 
levels of the alveolar bone were concluded through a 
measure of the distances within the cementoenamel 
junction (CEJ) and the alveolar bone crest. AL was 
concluded to be the distance within the CEJ versus 
the coronal extent of the connective tissue attached to 
the cementum. ABL and AL values were obtained from 
within mesial and distal regions of the mandibular first 
molars. All averages of the measurements performed 
were used to analyzing the data.
Intra-examiner reproducibility
Before histomorphometric and immunohistochemical 
analysis, the examiner (K.G.), who was blinded to 
the groups and treatments, evaluated 20 specimens 
twice, with one-week interval between the measures. 
Bland-Altman plots along with intraclass correlation 
coefficients were used to perform the Intra examiner 
agreement and reliability measures.25 Bland–
Altman plots reflected the agreements within the 
two values obtained within one-week interval in 
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the histomorphometric and immunohistochemical 
parameters.
Statistical analysis
The Shapiro–Wilk test was used to determine if the 
data were normally distributed. Comparisons of the 
biochemical parameters, histomorphometric data, and 
immunohistochemical scores were analyzed using the 
Kruskal–Wallis nonparametric test, followed by post-
hoc group comparisons with the Bonferroni-adjusted 
Mann–Whitney U test. The Spearman’s rank correlation 
test was used to detect the relationships among 
biochemical parameters, histomorphometric data, and 
immunohistochemical scores. All tests were performed 
using statistical software (SPSS Inc., version 19.0, 




Table 1 shows the alveolar bone area in the 
furcation region, alveolar bone level, and attachment 
loss values. The alveolar bone area of furcation 
was greater in control groups (p<0.001). However, 
no significant differences in the amount of alveolar 
bone in the furcation area in experimental groups 
were observed (p>0.05). ABL and AL were higher in 
groups 3 and 4 when compared with groups 1 and 
2 (P<0.001). On the other hand, ABL and AL values 
decreased in group 4 after EA administration than in 
group 3 (p<0.01). No significant differences in the 
alveolar bone area of furcation, ABL, and AL values 
between groups 1 and 2 were observed (p>0.05). 
Figure 1 shows histologic images.
Immunohistochemical findings
Figure 2 shows Immunoreactivity findings of IL-10, 
IL-6, and TNF-α in gingival tissues. IL-6 and TNF-α 
immunoreactivities were greater in group 3 among 
the groups (p<0.001). TNF-α immunoreactivity was 
statistically decreased after EA administration in 
group 4 when compared with group 3 (P<0.001). IL-6 
immunoreactivity was statistically lower in group 4 
than those in other groups (P<0.001). 
IL-10 immunoreactivity was significantly greater 
in group 2 than group 1 (p<0.01), and its level was 
lower in group 3 than in groups 1, 2, and 4 (p<0.001). 
Figure 3 shows immunohistochemical images.
Biochemical findings 
Serum and gingival tissue MPO activities were 
higher in group 3 than in groups 1 and 2 (p<0.05). 
After EA administration in group 4, MPO activities in 
the gingival tissue and serum significantly decreased 
when compared with groups 1, 2, and 3 (p<0.05). 
On the other hand, no significant difference was 
found in gingival 8-OHdG levels between group 3 
and the control groups (p>0.05). However, after 
EA administration in group 4, 8-OHdG levels in the 
gingival tissue significantly decreased when compared 
with groups 2 and 3, and its serum level in group 
4 presented the lowest value when compared with 
those of other groups (p<0.05). EA administration in 
groups 2 and 4 significantly increased in serum GSH 
levels compared to groups 1 and 3 (p<0.05), but not 
in gingival tissue (p>0.05). Figures 4 and 5 show the 
biochemical findings for gingival tissue and serum 
values, respectively.
Correlations
Table 2 shows the correlation coefficients. When 










Alveolar Bone Area (%) 64.08±5.57 64.26±4.55 46.70±4.37*† 51.47±5.71*†
Attachment level (μm) 127.79±18.64 128.64±13.52 525.57±23.64*† 407.25±64.30*†‡
Alveolar Bone Level (μm) 436.26±21.45 479.19±35.60 1205.47±71.40*† 1085.63±90.47*†‡
Table 1- Percentage of Alveolar Bone in Furcation Area, Alveolar Bone Level, and Attachment Level
Data are expressed as the mean ± standard deviation. 
p<0.05 was considered statistically significant.
Group 1: control-systemic saline, Group 2: control-systemic ellagic acid, Group 3: experimental periodontitis-systemic saline, Group 4: 
experimental periodontitis-systemic ellagic acid. 
* Statistically significant difference from Group 1 (p<0.001).
† Statistically significant difference from Group 2 (p<0.001).
‡ Statistically significant difference from Group 3 (p<0.01).
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positive correlation was observed in levels of MPO, 
8-OHdG in the gingival tissue, and H-score values 
of IL-6, TNF-α (p<0.001). Also, we found a positive 
correlation between gingival GSH levels and IL-10 
H-score values (p=0.018). Furthermore, TNF-α and 
IL-10 H-score values were correlated with the alveolar 
bone level, alveolar bone area, and attachment level 
(p<0.001). In contrast, we found significant negative 
CEJ: Cemento-enamel junction, CTA: Connective tissue attachment, AC: Alveolar crest
Figure 1- (A) Sections from the mesiodistal aspects throughout the mandibular first molars in the control group (Group 1) (H&E, 4×), (B) 
Sections from the mesiodistal aspects throughout the mandibular first molars in Group 2 (H&E, 4×), (C) Sections from the mesiodistal 
aspects throughout the mandibular first molars in Group 3 (H&E, 4×), (D) Sections from the mesiodistal aspects throughout the mandibular 
first molars in Group 4 (H&E, 4×)
Figure 2- HSCORE Values of IL-10, IL-6 and TNF-α Immunoreactivity in the periodontal ligament for all groups (A) TNF-α immunoreactivity; 
(B) IL-6 immunoreactivity; (C) IL-10 immunoreactivity
Data are expressed as the mean ± standard deviation. 
p<0.05 was considered statistically significant.
Group 1: control-systemic saline, Group 2: control-systemic ellagic acid, Group 3: experimental periodontitis-systemic saline, Group 4: 
experimental periodontitis-systemic ellagic acid. 
* Statistically significant difference from Group 1 (p<0.01).
† Statistically significant difference from Group 2 (p<0.001)
‡ Statistically significant difference from Group 3 (p<0.001)
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correlations between the TNF-α and IL-10 H-score 
values (p<0.001).
Discussion 
Over the past decade, polyphenols have received 
increasing attention from researchers concerning 
human health, especially regarding dental caries 
Group 1: control-systemic saline, Group 2: control-systemic ellagic acid, Group 3: experimental periodontitis-systemic saline, Group 4: 
experimental periodontitis-systemic ellagic acid.
Figure 3- TNF-α, IL-6, and IL-10 immunoreactivity in the periodontal tissues of the rats for all groups. A) Group 1; B) Group 2; C) Group 
3; D) Group 4
Data are expressed as the mean ± standard deviation. 
p<0.05 was considered statistically significant.
Group 1: control-systemic saline, Group 2: control-systemic ellagic acid, Group 3: experimental periodontitis-systemic saline, Group 4: 
experimental periodontitis-systemic ellagic acid. 
* Statistically significant difference from Group 1 (p<0.05).
† Statistically significant difference from Group 2 (p<0.05).
‡ Statistically significant difference from Group 3 (p<0.05).
Figure 4- Levels of GSH, MPO, and 8-OHdG in rat gingival tissue
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and periodontal disease.3,10 The protective effects of 
polyphenols have been investigated in many animal 
studies4,7–9, however, few studies focusing on the 
therapeutic effects of polyphenols in periodontal 
lesions are available.1 In our study, we focused on 
the antioxidative and inflammatory effects of EA on 
periodontal repair related to experimentally induced 
periodontitis in rats and investigated their effects on 
the alveolar bone loss after EA administration. To the 
best knowledge, our study is the first to show that 
EA may provide curative effects on the periodontal 
tissues by reducing gingival oxidative stress and pro-
inflammatory markers, and alveolar bone loss in the 
periodontal repair process after EP in rats.
In a previous study, daily oral administration of 7.5 
mg/kg and 15 mg/kg EA effectively reversed abnormal 
changes in biochemical and hematological parameters 
in isoproterenol (ISO)-treated rats, returning them to 
Data are expressed as the mean ± standard deviation. 
p<0.05 was considered statistically significant.
Group 1: control-systemic saline, Group 2: control-systemic ellagic acid, Group 3: experimental periodontitis-systemic saline, Group 4: 
experimental periodontitis-systemic ellagic acid. 
* Statistically significant difference from Group 1 (p<0.05).
† Statistically significant difference from Group 2 (p<0.05).
‡ Statistically significant difference from Group 3 (p<0.05).
Figure 5- Levels of GSH, MPO, and 8-OHdG in rat serum
G_MPO G_8OHdG G_GSH IL-10 IL-6 TNF-α ABA AL ABL
G_MPO r .511** -.155 -.285 .756** .453** -.269 .302 .265
p .001 .339 .075 .000 .003 .093 .058 .099
G_8OHdG r .511** -.268 -.039 .411** .283 -.051 -.048 -.032
p .001 .094 .810 .008 .077 .753 .768 .846
G_GSH r -.155 -.268 .372* -.139 -.246 .137 -.227 -.213
p .339 .094 .018 .392 .125 .399 .160 .187
IL-10 r -.285 -.039 .372* -.270 -.649** .784** -.825** -.765**
p .075 .810 .018 .093 .000 .000 .000 .000
IL-6 r .756** .411** -.139 -.270 .514** -.140 .292 .243
p .000 .008 .392 .093 .001 .389 .068 .131
TNF-α r .453** .283 -.246 -.649** .514** -.605** .601** .549**
p .003 .077 .125 .000 .001 .000 .000 .000
ABA r -.269 -.051 .137 .784** -.140 -.605** -.693** -.688**
p .093 .753 .399 .000 .389 .000 .000 .000
AL r .302 -.048 -.227 -.825** .292 .601** -.693** .851**
p .058 .768 .160 .000 .068 .000 .000 .000
ABL r .265 -.032 -.213 -.765** .243 .549** -.688** .851**
p .099 .846 .187 .000 .131 .000 .000 .000
Table 2- The Spearman's rank correlation (r) among groups regarding MPO, 8-OHdG, GSH levels, H-Score values of TNF-α, IL-6, IL-10 
and alveolar bone loss, alveolar bone area, and attachment level in all groups
** Correlation is significant at the 0.01 level.
*Correlation is significant at the 0.05 level. 
G, gingival tissue; MPO, myeloperoxidase; 8-OHdG, 8-Hydroxydeoxyguanosine; IL, interleukin; TNF-α, Tumor necrosis factor-alpha; ABA, 
alveolar bone area; AL, attachment level; ABL, alveolar bone level. 
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near-normal levels.26 The study showed that the higher 
dose of EA (15 mg/kg) was more effective in restoring 
biochemical parameters to normal than the lower dose 
(7.5 mg/kg).26 In another study of Favarin, et al.11 
(2013), they evaluated the anti-inflammatory effect 
of EA on acute lung injury and reported that 10mg\kg 
EA application had positive results on inflammatory 
cytokine levels. Since an effective dose has not yet 
been investigated in the treatment of periodontal 
diseases, in our study, we applied a 15 mg/kg dose 
of EA,14,26,27 reporting both its anti-inflammatory and 
anti-oxidant effects.
In our study, we induced experimental periodontitis 
for 14 days. Observational periods of 15 days or 
fewer are recommended in the EP model because 
rats have a large capacity to adapt to inflammatory 
stimulation.2,21 In our study, clinical symptoms such as 
edema, redness, bleeding, and mobility in the teeth 
were observed in the gingival tissues of the rats due 
to EP on the 14th day following the ligature placement. 
Moreover, after the rats were euthanized on the 28th 
day of study, the histomorphometric analysis showed 
that periodontitis was successfully induced in the 
experimental groups over the experimental 14-day 
period. These outcomes are in accordance with several 
previous studies.2,21 Herein, histologic assessments 
also showed greater degrees of alveolar bone 
resorption and periodontal tissue destruction in the 
rats of group 3 when compared with those of control 
groups. Nevertheless, our study demonstrated that 
rats treated with EA provided significant attachment 
and alveolar bone level gain. However, no previous 
studies have looked at the effects of EA on periodontal 
tissue destruction. The results of our study indicate 
that ellagic acid may reduce alveolar bone loss during 
periodontal repair after EP in the rat model.
Similar to previous studies,28,29 immunohistochemical 
results of our study showed that group 3 had the 
lowest IL-10 level and highest IL-6 and TNF-α levels 
in gingival tissues compared to the control groups. 
According to our findings, rats treated with EA (15 
mg/kg) had significantly reduced IL-6 and TNF-α 
levels and increased IL-10 levels in gingival tissues. 
A previous review reported that ellagic acid reduced 
TNF-α and IL-6 levels in vivo and in vitro.30 A study 
has reported that TNF-α levels, which increase with the 
development of colonic inflammation, decreased after 
administration of EA.31 Another study observed that 
EA efficiently suppressed LPS-induced increased IL-6 
levels depending on the dose.6 Moreover, Favarin, et 
al.27 (2013) stated that EA decreased IL-6 levels and 
elevated IL-10 levels in bronchoalveolar lavage fluid. 
Umesalma and Sudhandiran32 (2010) observed that 
EA regulates the inflammatory process by reducing 
the production of inflammatory cytokines through 
inhibition of NF-kB expression.32 Additionally, Usta, 
et al.33 (2013) suggested that the anti-inflammatory 
effect of EA may occur due to the suppression of 
cyclooxygenase (COX) protein activation. Granica, et 
al.34 (2016) stated that Geum urbanum L. roots, which 
is the rich source of EA derivatives, have a beneficial 
effect on gingival inflammation because it decreases 
TNF-α levels due to its effect on neutrophils and can 
be used in inflammation of mucositis, gingivitis, and 
periodontitis. Therefore, consistent with previous 
study findings,6,11,30–32 our results indicate that 
anti-inflammatory activity of EA in periodontium is 
evidenced by reducing proinflammatory cytokines 
and increasing anti-inflammatory cytokine activities 
in gingival tissue.
Several studies have proved that periodontal tissue 
loss is associated with increased reactive oxygen 
species and decreased antioxidant levels.35–37 Akman, 
et al.38 (2013) stated that MPO is the marker most 
commonly used for determining increased oxidative 
stress in periodontal diseases. Moreover, various 
studies found that rats with experimental periodontitis 
had high MPO activities in the gingival tissue compared 
to the control group.28,29,38,39 In accordance with these 
studies,28,29,38,39 our results showed that gingival 
tissue and serum MPO levels were higher in group 
3 compared to the control groups. These results 
indicate that MPO activity measurement may be a 
useful marker for periodontitis. On the other hand, 
we determined that 8-OHdG levels, which are the 
markers of oxidative DNA damage, were higher in 
the gingival tissue and serum in group 3 compared 
to the control groups, although it was not statistically 
significant. Previous experimental studies have shown 
that 8-OHdG levels are positively correlated with 
periodontal tissue loss.40,41 The difference of our study 
may be related to the treatment with saline after 
ligature removal, improving the periodontal lesion 
and some reducing 8-OHdG levels. The findings of 
this study showed that, although no difference was 
observed in the control group treated with EA in the 
gingival tissue and serum MPO and 8-OHdG levels, 
these levels decreased in group 4 treated with EA 
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when compared with the control groups. Moreover, 
analysis between experimental groups showed that 
EA significantly increased serum GSH levels. Many 
experimental studies have shown that EA significantly 
reduced the levels of MPO and increased the levels 
of GSH.13,42 Tomofuji, et al.43 (2009) stated that the 
production of ROS in the periodontal inflammation 
gradually reduced after ligature removal. Consistent 
with the study of Tomofuji, et al.43 (2009), our study 
indicated that EA administered systemically for 14 
days had sufficient effect on the serum of experimental 
periodontitis rats but could not increase GSH levels in 
the gingival tissue adequately. Based on the results of 
this study, we deduce that EA may improve gingival 
oxidative stress and increase systemic antioxidant 
levels. However, there is no study in the literature to 
which we could compare our results.
However, our study has some limitations. The first 
limitation was the effect of EA on bone resorption 
based on the evaluation of biomarker levels and that 
the exact mechanism was not fully demonstrated. 
Second, ellagic acid levels were not evaluated in body 
fluids, so we could not determine how much systemic 
administered ellagic acid reached the gingival tissue. 
Third, our study is not a dose-dependent experimental 
study. Therefore, the effective and non-toxic dose 
of EA can be determined in periodontal tissues by 
experimental studies with different doses. Fourth, 
our study did not evaluate the effect of EA application 
on microbial dental biofilm in the periodontium. 
However, we reported that EA had anti-biofilm 
activity against bacterial pathogens.7 In addition to 
systemic administration, if EA was applied locally, 
EA’s anti-biofilm activity would be observed better 
in periodontal tissues. On the other hand, our study 
suggests that EA healed gingival oxidative stress and 
periodontal inflammation unconnected to the biofilm 
activity. Additionally, the experimental periodontitis 
model is not directly equivalent to chronic disease in 
humans. Future studies should further evaluate how 
EA administration affects gingival oxidative stress and 
periodontal inflammation in periodontitis patients.
Conclusions
Our study showed that EA provides significant 
improvements on gingival oxidative stress and 
inflammatory markers and alveolar bone resorption 
in the periodontal repair process after experimental 
periodontitis within the limits of the study. These 
effects could be attributed to the antioxidative and 
anti-inflammatory nature of ellagic acid. Thus, EA 
may have therapeutic potential on periodontitis. 
However, studies should further explore and show the 
therapeutic mechanism of ellagic acid in periodontal 
inflammation and to examine its clinical effectiveness 
in human periodontal diseases, thus eliminating the 
limitations.
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